On September 17, 2026, the International Training Program on Clinical Application of Carbon Ion Therapy System (Third Session) was launched at the Wuwei Heavy Ion Cancer Center. It gathers top experts from around the world to share the technological achievements and clinical standardization experiences of domestically developed heavy ion technology, promoting the high-quality development of heavy ion therapy.

In the golden autumn, we gather for a grand event, opening our doors to the future. The 2026 China International Fair for Trade in Services (CIFTIS) grandly opened in Beijing. At this year's fair, Gansu Province presents its exhibition under the theme "Symphony of the Silk Road, Auspicious Gansu," featuring the "Gansu Service Decoding Journey." The exhibition highlights four chapters of development: the journey of inheritance along a road, the journey of value‑added transformation of a kilowatt of electricity, the journey of sublimation of a single medicine, and the journey of transformation of a single letter.

The 7th China (Gansu) Traditional Chinese Medicine Industry Expo is about to open in Longxi. To further amplify the brand impact of heavy ion therapy as a "national heavy instrument" and highlight Gansu's distinctive strengths in nuclear medicine, and in alignment with the province's integrated development strategy for biomedicine and nuclear medicine, Gansu Wuwei Cancer Hospital held a promotion conference on the high‑quality integrated development of heavy ion and nuclear medicine technologies and the green access medical model in Dingxi on September 2. The hospital will also feature a dedicated heavy ion exhibition at the 7th TCM Industry Expo. By integrating cutting‑edge heavy ion radiotherapy, targeted radionuclide therapy, and the rich advantages of traditional Chinese medicine resources in Gansu, the hospital aims to build a platform for promoting advanced cancer technologies, facilitate the distribution of high‑quality medical resources to the grassroots level, and support the

Debuting in the Capital! China's Heavy Ion Technology Goes Global. The Gansu Province Wuwei Tumor Hospital showcased domestic heavy ion technology in Beijing, highlighting breakthroughs and international achievements in precise tumor diagnosis and treatment, thereby contributing to "Healthy China" and the development of the Belt and Road Initiative.

Experts from the medical and health sectors of multiple countries visited the Wuwei Heavy Ion Center for exchanges and learning. As a benchmark for the clinical effectiveness of domestically produced heavy ion therapy, the center has attracted global experts to conduct inspections, share "Chinese experiences," and promote international medical cooperation and technological progress.

In July 2026, cutting-edge achievements in China's heavy ion therapy sparked widespread discussion at the BMIT-GRN International Academic Symposium. Wuwei Cancer Hospital showcased its first independently developed heavy ion system and AI-enabled innovative projects, covering over a hundred types of tumors with efficacy surpassing international standards, thereby promoting deep integration of industry, academia, and research as well as enhanced international collaboration.

Leading Experts Convene in Wuwei to Chart New Course for Precision Radiotherapy in Lung Cancer

Gansu Province Wuwei Tumor Hospital has achieved a breakthrough in heavy ion fusion nuclear medicine therapy for tumors, hosting the nation's first and second heavy ion systems. It has launched alpha/beta radionuclide-targeted therapies to overcome challenges such as liver and pancreatic cancers, led the formulation of national diagnostic and treatment guidelines, and is guiding China's nuclear medicine sector toward global leadership.

Gansu Tianshui held a promotion meeting for the high-quality integrated development of heavy ion and nuclear medicine technologies. The Gansu Province Wuwei Cancer Hospital, leveraging its dual-center linkage advantages, has cumulatively completed over 3,000 treatments, established a green medical care model, and provided cutting-edge treatment hope for cancer patients.

Professor Kohei Takizawa, a leading Japanese expert, has joined the Gastrointestinal Cancer Center of Wuwei Tumor Hospital in Gansu Province on a regular basis to support the development of its National Key Discipline. Through teaching high-difficulty surgeries, conducting seminars on cutting-edge technologies, and fostering international scientific collaboration, he aims to elevate the diagnosis and treatment standards for digestive system tumors in the Hexi Corridor region, driving the discipline from technical following to standard-setting.